Gene: RPS6KC1
Official Full Name: ribosomal protein S6 kinase C1provided by HGNC
Gene Summary: Sphingosine kinase catalyzes the formation of sphingosine 1 phosphate, a lipid cellular messenger. The protein encoded by this gene can bind to sphingosine kinase and to phosphatidylinositol 3-phosphate, suggesting a role in sphingosine 1 phophate signaling. The encoded protein can also bind to peroxiredoxin-3 and may help transport it to mitochondria. [provided by RefSeq, Mar 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27995 | RPS6KC1 Knockout cell line (HeLa) | Human | RPS6KC1 | 1:3~1:6 | Negative | Online Inquiry |
KO27996 | RPS6KC1 Knockout cell line (HCT 116) | Human | RPS6KC1 | 1:2~1:4 | Negative | Online Inquiry |
KO27997 | RPS6KC1 Knockout cell line (HEK293) | Human | RPS6KC1 | 1:3~1:6 | Negative | Online Inquiry |
KO27998 | RPS6KC1 Knockout cell line (A549) | Human | RPS6KC1 | 1:3~1:4 | Negative | Online Inquiry |
RPS6KC1 Gene Knockout Cell Lines are genetically modified cell lines that have undergone precise gene editing to inactivate the RPS6KC1 gene, which encodes a protein that plays a crucial role in cellular signaling pathways. These cell lines serve as powerful tools for researchers investigating the biological functions associated with the RPS6KC1 gene, including its role in cell growth, proliferation, and response to various stimuli. The knockout mechanism leverages CRISPR/Cas9 technology, ensuring high specificity and efficiency in gene disruption, which is essential for producing reliable and reproducible experimental results.
The RPS6KC1 gene is a subject of significant interest due to its potential associations with developmental processes and diseases, including cancer. By providing a means to study the loss of function of this gene, the cell lines enable researchers to elucidate the pathways and cellular mechanisms that are influenced by RPS6KC1 expression. This is particularly valuable in drug discovery and translational research, where understanding the molecular underpinnings of disease can lead to the identification of novel therapeutic targets.
One of the primary advantages of using RPS6KC1 Gene Knockout Cell Lines lies in their ability to provide a clear and controlled environment to study gene function without the interference of other gene activities. Unlike traditional knockdown approaches, which may result in incomplete loss of function or non-specific effects, complete knockout ensures a more definitive analysis of RPS6KC1’s biological roles. Additionally, these cell lines can be combined with various assays for drug screening, high-throughput screening, and molecular biology techniques, enhancing their versatility in research applications.
For researchers and clinicians, the RPS6KC1 Gene Knockout Cell Lines present an opportunity to delve deeper into gene-related pathways with enhanced precision, thereby facilitating advances in understanding potential therapeutic avenues. Our company specializes in developing high-quality genetically modified cell lines backed by robust validation processes and a commitment to excellence in biological research products. Choose RPS6KC1 Gene Knockout Cell Lines for your next research endeavor and unlock innovative insights into gene function and disease dynamics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.